{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:17:35Z","timestamp":1781752655301,"version":"3.54.5"},"reference-count":59,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2021.9696","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T10:21:39Z","timestamp":1611570099000},"source":"Crossref","is-referenced-by-count":11,"title":["Therapeutic plasma exchange as a first\u2011choice therapy for axonal Guillain\u2011Barr\u00e9 syndrome: A case\u2011based review of the literature (Review)"],"prefix":"10.3892","volume":"21","author":[{"given":"Adina","family":"Stoian","sequence":"first","affiliation":[{"name":"Neurology Clinic I, Mures County Clinical Emergency Hospital Targu Mures, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgiana","family":"\u0218erban","sequence":"additional","affiliation":[{"name":"Neurology Clinic I, Mures County Clinical Emergency Hospital Targu Mures, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Bajko","sequence":"additional","affiliation":[{"name":"Neurology Clinic I, Mures County Clinical Emergency Hospital Targu Mures, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Andone","sequence":"additional","affiliation":[{"name":"Neurology Clinic I, Mures County Clinical Emergency Hospital Targu Mures, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana","family":"Mosora","sequence":"additional","affiliation":[{"name":"Neurology Clinic I, Mures County Clinical Emergency Hospital Targu Mures, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"B\u0103la\u0219a","sequence":"additional","affiliation":[{"name":"Neurosurgery Clinic, Mures County Clinical Emergency Hospital Targu Mures, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"key20220302134045_b1-ETM-0-0-09696","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/2230-8229.98709","article-title":"The landry-guillain-barr\u00e9 strohl syndrome 1859 to 1992 a historical perspective","volume":"1","author":"Afifi","year":"1994","journal-title":"J Family Community Med"},{"key":"key20220302134045_b2-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/00207454.2014.913588","article-title":"Pathophysiology and diagnosis of guillain-barr\u00e9 syndrome-challenges and needs","volume":"125","author":"Dash","year":"2015","journal-title":"Int J Neurosci"},{"key":"key20220302134045_b3-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1212\/01.wnl.0000081231.08914.a1","article-title":"Differences in patterns of progression in demyelinating and axonal guillain-barre syndromes","volume":"61","author":"Hiraga","year":"2003","journal-title":"Neurology"},{"key":"key20220302134045_b4-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the american society for apheresis: The eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"key20220302134045_b5-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2478\/jccm-2020-0008","article-title":"Guillain-Barr\u00e9 and acute transverse myelitis overlap syndrome following obstetric surgery","volume":"6","author":"Stoian","year":"2020","journal-title":"J Crit Care Med (Targu Mures)"},{"key":"key20220302134045_b6-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1529-8027.2012.00397.x","article-title":"Retrospective analysis of slovenian patients with guillain-barr\u00e9 syndrome","volume":"17","author":"Omejec","year":"2012","journal-title":"J Peripher Nerv Syst"},{"issue":"1063","key":"key20220302134045_b7-ETM-0-0-09696","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2010.213421","article-title":"Axonal guillain-barr\u00e9 syndrome is underestimated in Europe?","volume":"81","author":"Kuwabara","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20220302134045_b8-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S1474-4422(13)70215-1","article-title":"Axonal guillain-barr\u00e9 syndrome: Concepts and controversies","volume":"12","author":"Kuwabara","year":"2013","journal-title":"Lancet Neurol"},{"key":"key20220302134045_b9-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1084\/jem.178.5.1771","article-title":"A bacterium lipopolysaccharide that elicits Guillain-Barr\u00e9 syndrome has a GM1 ganglioside-like structure","volume":"178","author":"Yuki","year":"1993","journal-title":"J Exp Med"},{"key":"key20220302134045_b10-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/1531-8249(199902)45:2<168::aid-ana6>3.0.co;2-6","article-title":"Anti-GD1a antibody is associated with axonal but not demyelinating forms of guillain-barr\u00e9 syndrome","volume":"45","author":"Ho","year":"1999","journal-title":"Ann Neurol"},{"key":"key20220302134045_b11-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.it.2003.12.004","article-title":"The guillain-barr\u00e9 syndrome: A true case of molecular mimicry","volume":"25","author":"Ang","year":"2004","journal-title":"Trends Immunol"},{"key":"key20220302134045_b12-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/mus.10488","article-title":"The refractory period of transmission is impaired in axonal guillain-barr\u00e9 sindromes","volume":"28","author":"Kuwabara","year":"2003","journal-title":"Muscle Nerve"},{"key":"key20220302134045_b13-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ana.410400414","article-title":"Acute motor axonal neuropathy: An antibody-mediated attack on axolemma","volume":"40","author":"Hafer-Macko","year":"1996","journal-title":"Ann Neurol"},{"key":"key20220302134045_b14-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/jnnp.2007.118000","article-title":"Neurophysiological criteria in the diagnosis of different clinical types of guillain-barre syndrome","volume":"79","author":"Kalita","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20220302134045_b15-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: Pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"key20220302134045_b16-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"key20220302134045_b17-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1212\/wnl.51.6.1656","article-title":"Two patterns of clinical recovery in guillain-barr\u00e9 syndrome with IgG anti-GM1 antibody","volume":"51","author":"Kuwabara","year":"1998","journal-title":"Neurology"},{"key":"key20220302134045_b18-ETM-0-0-09696","doi-asserted-by":"crossref","first-page":"426","DOI":"10.31925\/farmacia.2020.3.7","article-title":"Understandig the mechanism of action of intravenous immunoglobulins: A ten years experience in treating guillain-barr\u00e9 syndrome","volume":"68","author":"Stoian","year":"2020","journal-title":"Farmacia"},{"key":"key20220302134045_b19-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/mus.880141111","article-title":"Interobserver agreement in the assessment of muscle strength and functional abilities in guillain-barr\u00e9 syndrome","volume":"14","author":"Kleyweg","year":"1991","journal-title":"Muscle Nerve"},{"key":"key20220302134045_b20-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/s0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"issue":"e0133520","key":"key20220302134045_b21-ETM-0-0-09696","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133520","article-title":"Subtypes and prognosis of guillain-barr\u00e9 syndrome in Southwest China","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"key20220302134045_b22-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/brain\/118.3.597","article-title":"Guillain-Barre syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies","volume":"118","author":"Ho","year":"1995","journal-title":"Brain"},{"key":"key20220302134045_b23-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/mus.23477","article-title":"Electrophysiological subtypes and prognosis of guillain-barr\u00e9 syndrome in northeastern China","volume":"47","author":"Ye","year":"2013","journal-title":"Muscle Nerve"},{"key":"key20220302134045_b24-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mus.26706","article-title":"Prognostic factors for the sequelae and severity of guillain-barr\u00e9 syndrome in children","volume":"60","author":"Estrade","year":"2019","journal-title":"Muscle Nerve"},{"key":"key20220302134045_b25-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"The plasma exchange\/sandoglobulin guillain-barr\u00e9 syndrome trial group. electrophysiological classification of guillain-barr\u00e9 syndrome: Clinical associations and outcome","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann Neurol"},{"key":"key20220302134045_b26-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1136\/jnnp.52.3.424-a","article-title":"A prospective study of acute idiopathic neuropathy. II. Antecedent events","volume":"51","author":"Winer","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20220302134045_b27-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1212\/wnl.38.3.375","article-title":"Immunologic studies of rabies vaccination-induced GBS","volume":"38","author":"Hemachudha","year":"1998","journal-title":"Neurology"},{"key":"key20220302134045_b28-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","article-title":"The guillain-barre\u00b4 syndrome and the 1992-1993 and 1993-1994 influenza vaccines","volume":"339","author":"Lasky","year":"1998","journal-title":"N Engl J Med"},{"key":"key20220302134045_b29-ETM-0-0-09696","doi-asserted-by":"crossref","first-page":"81","DOI":"10.17925\/ENR.2015.10.01.81","article-title":"A retrospective study on patients with guillain-barr\u00e9 syndrome treated with therapeutic plasma exchange and other treatment options-a centre's experience","volume":"10","author":"Kozanoglu","year":"2015","journal-title":"Eur Neurological Rev"},{"key":"key20220302134045_b30-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.lpm.2019.03.016","article-title":"Therapeutic plasma exchange in guillain-barr\u00e9 syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"48","author":"Huy","year":"2019","journal-title":"Presse Med"},{"issue":"CD00179","key":"key20220302134045_b31-ETM-0-0-09696","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001798.pub3","article-title":"Plasma exchange for guillain-barr\u00e9 syndrome","volume":"2","author":"Chevret","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"key20220302134045_b32-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/ana.410230406","article-title":"Plasmapheresis and guillain-barr\u00e9 syndrome: Analysis of prognostic factors and the effect of plasmapheresis","volume":"23","author":"McKhann","year":"1998","journal-title":"Ann Neurol"},{"key":"key20220302134045_b33-ETM-0-0-09696","first-page":"346","article-title":"The efficacy of plasma exchange in the removal of plasma components","volume":"104","author":"Derksen","year":"1984","journal-title":"J Lab Clin Med"},{"key":"key20220302134045_b34-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.410410304","article-title":"Appropriate number of plasma exchanges in Guillain-Barr\u00e9 syndrome","volume":"41","year":"1997","journal-title":"Ann Neurol"},{"key":"key20220302134045_b35-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1007\/s001340051323","article-title":"French cooperative group on plasma exchange in guillain-barr\u00e9 syndrome. Cost-effectiveness of plasma exchange therapy for the treatment of guillain-barr\u00e9 syndrome","volume":"26","author":"Esp\u00e9rou","year":"2000","journal-title":"Intensive Care Med"},{"key":"key20220302134045_b36-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/jca.20143","article-title":"Complications of therapeutic plasma exchange: A prospective study of 1,727 procedures","volume":"22","author":"Shemin","year":"2007","journal-title":"J Clin Apher"},{"key":"key20220302134045_b37-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"475","DOI":"10.4103\/0378-6323.44303","article-title":"Histamine 2 blocker potentiates the effects of histamine 1 blocker in suppressing histamine-induced wheal","volume":"74","author":"Dhanya","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"key20220302134045_b38-ETM-0-0-09696","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O","article-title":"Axonal guillain-barr\u00e9 syndrome: Relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan","volume":"48","author":"Ogawara","year":"2000","journal-title":"Ann Neurol"},{"key":"key20220302134045_b39-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/1531-8249(199911)46:5<701::aid-ana4>3.0.co;2-7","article-title":"Epidemiological, clinical, and electrodiagnostic findings in childhood guillain-barr\u00e9 syndrome: A reappraisal","volume":"46","author":"Paradiso","year":"1999","journal-title":"Ann Neurol"},{"key":"key20220302134045_b40-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.ejpn.2017.07.005","article-title":"Acute axonal neuropathy subtype of guillain barr\u00e9 syndrome in a French pediatric series: Adequate follow-up may require repetitive electrophysiological studies","volume":"21","author":"Chareyre","year":"2017","journal-title":"Eur J Paediatr Neurol"},{"key":"key20220302134045_b41-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/s0887-8994(02)00626-4","article-title":"Outcome of axonal and demyelinating forms of guillain-barr\u00e9 syndrome in children","volume":"28","author":"Tekgul","year":"2003","journal-title":"Pediatr Neurol"},{"key":"key20220302134045_b42-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41016-018-0122-y","article-title":"Prognostic factors of guillain-barr\u00e9 syndrome: A 111-case retrospective review","volume":"14","author":"Zhang","year":"2018","journal-title":"Chin Neurosurg J"},{"key":"key20220302134045_b43-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4103\/0972-2327.82793","article-title":"Clinical features and prognosis with guillain-barr\u00e9 syndrome","volume":"14","author":"Akbayram","year":"2011","journal-title":"Ann Indian Acad Neurol"},{"issue":"95","key":"key20220302134045_b44-ETM-0-0-09696","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-13-95","article-title":"Guillain-Barre syndrome: Natural history and prognostic factors: A retrospective review of 106 cases","volume":"13","author":"Gonzalez-Suarez","year":"2013","journal-title":"BMC Neurol"},{"key":"key20220302134045_b45-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/mus.880150415","article-title":"Guillain-Barr\u00e9 syndrome in children: Clinical course, electrodiagnosis, and prognosis","volume":"15","author":"Bradshaw","year":"1992","journal-title":"Muscle Nerve"},{"issue":"CD001798","key":"key20220302134045_b46-ETM-0-0-09696","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001798.pub2","article-title":"Plasma exchange for guillain-barr\u00e9 syndrome","volume":"7","author":"Rapha\u00ebl","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key20220302134045_b47-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","article-title":"Early recognition of poor prognosis in guillain-barre syndrome","volume":"76","author":"Walgaard","year":"2011","journal-title":"Neurology"},{"key":"key20220302134045_b48-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1440-1754.2008.01325.x","article-title":"Clinical presentation and prognosis of childhood guillain-barr\u00e9 syndrome","volume":"44","author":"Lee","year":"2008","journal-title":"J Paediatr Child Health"},{"key":"key20220302134045_b49-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1136\/jnnp.63.5.649","article-title":"Micturitional disturbance in patients with guillain-barre syndrome","volume":"63","author":"Sakakibara","year":"1997","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"key20220302134045_b50-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/00003246-200301000-00044","article-title":"Early predictors of mechanical ventilation in guillain-barr\u00e9 syndrome","volume":"31","author":"Sharshar","year":"2003","journal-title":"Crit Care Med"},{"key":"key20220302134045_b51-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of guillain-barr\u00e9 syndrome","volume":"7","author":"Van Doorn","year":"2008","journal-title":"Lancet Neurol"},{"key":"key20220302134045_b52-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1007\/s10875-010-9407-4","article-title":"IVIG treatment and prognosis in guillain-barr\u00e9 syndrome","volume":"30 (Suppl)","author":"Van Doorn","year":"2010","journal-title":"J Clin Immunol"},{"key":"key20220302134045_b53-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/0310057X1003800225","article-title":"Plasmapheresis treatment in guillain-barr\u00e9 syndrome: Potential benefit over intravenous immunoglobulin","volume":"38","author":"Buzzigoli","year":"2010","journal-title":"Anaesth Intensive Care"},{"key":"key20220302134045_b54-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1526-0968.2004.00183.x","article-title":"Plasmapheresis treatment in guillain-barr\u00e9 syndrome: Potential benefit over IVIg in patients with axonal involvement","volume":"8","author":"Dada","year":"2004","journal-title":"Ther Apher Dial"},{"key":"key20220302134045_b55-ETM-0-0-09696","first-page":"263","article-title":"Clinical outcome of Guillain-Barr\u00e9 syndrome with various treatment methods and cost effectiveness: A study from tertiary care center in South India: Yashoda GBS Registry","volume":"19","author":"Chaudhuri","year":"2014","journal-title":"Neurol Asia"},{"key":"key20220302134045_b56-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/(sici)1098-1101(1999)14:3<107::aid-jca1>3.0.co;2-3","article-title":"Treatment of guillain-barr\u00e9 syndrome: A cost-effectiveness analysis","volume":"14","author":"Nagpal","year":"1999","journal-title":"J Clin Apher"},{"issue":"101","key":"key20220302134045_b57-ETM-0-0-09696","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-11-101","article-title":"Cost-Minimization analysis of the direct costs of TPE and IVIg in the treatment of guillain-barr\u00e9 syndrome","volume":"11","author":"Winters","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"key20220302134045_b58-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2478\/jccm-2020-0021","article-title":"Therapeutic plasma exchange: An indispensable therapy for severe neurological condition","volume":"6","author":"Balasa","year":"2020","journal-title":"J Crit Care Med (Targu Mures)"},{"key":"key20220302134045_b59-ETM-0-0-09696","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.braindev.2004.09.013","article-title":"Child with guillain-barr\u00e9 syndrome responding to plasmapheresis: A case report","volume":"3","author":"Al Hamdani","year":"2020","journal-title":"Case Rep Acute Med"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T05:39:34Z","timestamp":1670909974000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2021.9696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":59,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,1,25]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2021.9696","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,25]]},"article-number":"265"}}